# Positron Emission Tomography in Determining Stage of Esophageal Cancer

> **NCT00004867** · NA · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 235 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** conventional surgery
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** radionuclide imaging
- **RADIATION:** fludeoxyglucose F 18
- **DRUG:** chemotherapy
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00004867
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2005-07
- **Final completion:** 2009-01
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2017-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004867, "Positron Emission Tomography in Determining Stage of Esophageal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00004867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*